The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.
Publication
, Journal Article
Luterbach, CL; Boshe, A; Henderson, HI; Cober, E; Richter, SS; Salata, RA; Kalayjian, RC; Watkins, RR; Hujer, AM; Hujer, KM; Rudin, SD; Doi, Y ...
Published in: Open Forum Infect Dis
January 2019
In the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE), trimethoprim-sulfamethoxazole (TMP-SMX) had a limited role in the treatment of less severe carbapenem-resistant Enterobacteriaceae (CRE) infections, especially urinary tract infections. Of tested CRE, only 29% were susceptible to TMP-SMX. Development of resistance further limits the use of TMP-SMX in CRE infections.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Open Forum Infect Dis
DOI
ISSN
2328-8957
Publication Date
January 2019
Volume
6
Issue
1
Start / End Page
ofy351
Location
United States
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Luterbach, C. L., Boshe, A., Henderson, H. I., Cober, E., Richter, S. S., Salata, R. A., … van Duin, D. (2019). The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. Open Forum Infect Dis, 6(1), ofy351. https://doi.org/10.1093/ofid/ofy351
Luterbach, Courtney L., Ashley Boshe, Heather I. Henderson, Eric Cober, Sandra S. Richter, Robert A. Salata, Robert C. Kalayjian, et al. “The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.” Open Forum Infect Dis 6, no. 1 (January 2019): ofy351. https://doi.org/10.1093/ofid/ofy351.
Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, et al. The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. Open Forum Infect Dis. 2019 Jan;6(1):ofy351.
Luterbach, Courtney L., et al. “The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.” Open Forum Infect Dis, vol. 6, no. 1, Jan. 2019, p. ofy351. Pubmed, doi:10.1093/ofid/ofy351.
Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, van Duin D. The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. Open Forum Infect Dis. 2019 Jan;6(1):ofy351.
Published In
Open Forum Infect Dis
DOI
ISSN
2328-8957
Publication Date
January 2019
Volume
6
Issue
1
Start / End Page
ofy351
Location
United States
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences